Your browser doesn't support javascript.
loading
Acute glycemic and insulin response of Fossence™ alone, or when substituted or added to a carbohydrate challenge: A three-phase, acute, randomized, cross-over, double blind clinical trial.
Shah, Priyali; Wolever, Thomas Ms; Jenkins, Alexandra L; Ezatagha, Adish; Campbell, Janice; Zurbau, Andreea; Jain, Manish; Gote, Manoj; Bhaduri, Anirban; Mullick, Ashim.
Afiliação
  • Shah P; Tata Chemicals Ltd-Innovation Centre, Pune, Maharashtra, India.
  • Wolever TM; INQUIS Clinical Research (formerly GI Labs), Canada.
  • Jenkins AL; INQUIS Clinical Research (formerly GI Labs), Canada.
  • Ezatagha A; INQUIS Clinical Research (formerly GI Labs), Canada.
  • Campbell J; INQUIS Clinical Research (formerly GI Labs), Canada.
  • Zurbau A; INQUIS Clinical Research (formerly GI Labs), Canada.
  • Jain M; Tata Chemicals Ltd-Innovation Centre, Pune, Maharashtra, India.
  • Gote M; Tata Chemicals Ltd-Innovation Centre, Pune, Maharashtra, India.
  • Bhaduri A; Tata Chemicals Ltd-Innovation Centre, Pune, Maharashtra, India.
  • Mullick A; Tata Consumer Products Ltd (formerly at Tata Chemicals Ltd-Innovation Centre), Pune, Maharashtra, India.
Heliyon ; 7(4): e06805, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33997376
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article